Unifeye Vision Partners Announces Leadership Change with New CEO
Unifeye Vision Partners Welcomes New Leadership
In a significant transition, Unifeye Vision Partners ("UVP" or the "Company"), a prominent operator of ambulatory surgery centers specializing in ophthalmology, has announced the appointment of Mark Garvin as the new Chief Executive Officer. Garvin takes over from Martin Rash, who will continue his role as Executive Chairman of the Board of Directors. This leadership change marks an exciting new chapter for the company.
Mark Garvin's Background and Vision
Mark Garvin brings an impressive portfolio with over 30 years in the healthcare sector. His recent experience includes a pivotal role at Banner Health, and prior to that, he spent nearly two decades at United Surgical Partners International ("USPI"). During his tenure at USPI, he was instrumental in steering the organization through transformative growth phases, leveraging both organic and acquisition-driven strategies to elevate it to one of the largest ASC operators in the nation.
Garvin's Strategic Focus
Expressing his enthusiasm about joining UVP, Garvin stated, "I am honored to partner with physicians and our teams to enhance patient access and improve the overall experience. We will prioritize measurable outcomes, operational excellence, and a differentiated patient experience, ensuring we deliver value to all stakeholders across the organization."
The Board's Perspective on Transition
The leadership change comes at a strategic moment for UVP, as noted by Chris Graber, Partner and Head of Healthcare with Waud Capital Partners, the Company's founding investor. He emphasized the significance of Garvin's appointment, stating that Rash's leadership had successfully navigated the company through rapid growth, positioning it strongly for the future. Martin Rash also expressed his optimism regarding Garvin’s capabilities, adding, "He has effectively supported physicians throughout his career in ASC growth and operational improvements. We are eager to see him lead UVP into this next growth phase."
Enhancing Eye Care Services
Under Garvin's guidance, Unifeye Vision Partners aims to bolster comprehensive eye care practices through initiatives such as ASC development and optimization. This will also include enhancing physician recruitment, operational advancements, and expanding services to fulfill the company’s mission of improving care and access in outpatient settings. The strategic approach is crafted to align with the growing demand within the healthcare sector.
About Unifeye Vision Partners
Unifeye Vision Partners operates as a physician-led ambulatory surgery center operator, specializing in integrated practice management services in ophthalmology. The company is committed to delivering extensive management and support services to a variety of eye care practices and specialized surgery centers. Currently, UVP oversees a robust network of 66 clinic locations and 19 ambulatory surgery centers, reflecting its solid presence in the industry.
About Waud Capital Partners
Waud Capital Partners is a private equity firm based in Chicago, established by Reeve B. Waud. With a strong focus on growth, the firm has amassed over 30 years of investing experience. They partner with skilled management teams to create leading companies within healthcare and technology sectors. Since its inception in 1993, Waud Capital has completed over 500 investments, influencing both new platforms and follow-on opportunities.
Contact Information
For further inquiries, contact Mark Garvin, CEO of Unifeye Vision Partners. Additionally, Mike Lehman from Waud Capital Partners is available for questions, with the firm’s main office reachable at (312) 676-8400.
Frequently Asked Questions
What prompted the leadership change at Unifeye Vision Partners?
The transition to Mark Garvin as CEO reflects the company's strategy to further enhance operational excellence and patient care.
What are Mark Garvin's plans for UVP?
Garvin aims to expand patient access and improve services in ambulatory surgery centers, emphasizing physician collaboration and operational improvements.
Who is succeeding Martin Rash?
Mark Garvin has been appointed as the new CEO, succeeding Martin Rash, who continues as Executive Chairman.
How many clinic locations does Unifeye Vision Partners operate?
Unifeye Vision Partners currently operates 66 clinic locations and 19 ambulatory surgery centers.
What is the focus of Waud Capital Partners?
Waud Capital Partners focuses on growth-oriented investments in healthcare and technology sectors, partnering with experienced management teams.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.